Extendicare (TSE:EXE) Stock Rating Upgraded by BMO Capital Markets

Extendicare (TSE:EXEGet Free Report) was upgraded by equities researchers at BMO Capital Markets to a “hold” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.

A number of other analysts also recently issued reports on the stock. Royal Bank of Canada increased their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. TD Securities increased their price objective on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research report on Thursday, November 14th.

Check Out Our Latest Report on Extendicare

Extendicare Stock Down 0.2 %

Shares of EXE opened at C$10.35 on Tuesday. Extendicare has a fifty-two week low of C$6.63 and a fifty-two week high of C$10.89. The company’s fifty day moving average is C$10.36 and its two-hundred day moving average is C$9.18. The firm has a market cap of C$863.91 million, a PE ratio of 15.22 and a beta of 1.26. The company has a quick ratio of 0.98, a current ratio of 0.60 and a debt-to-equity ratio of 305.80.

Extendicare (TSE:EXEGet Free Report) last issued its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. During the same period in the previous year, the company earned $0.13 EPS. Analysts forecast that Extendicare will post 0.6134729 earnings per share for the current year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Recommended Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.